SCHEMBL7656593

SCHEMBL7656593

N#CC(C#N)=C1N(CCN(Cc2cccc(CN3CCCCC3)c2)C(=O)c2cccs2)CCN1Cc1cccc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.55
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.38
OPRM1 P35372 4/20 0.35
NPFFR1 Q9GZQ6 4/20 0.35
NPFFR2 Q9Y5X5 4/20 0.35
OPRK1 P41145 3/20 0.35
CHRM2 P08172 3/20 0.35
CHRM3 P20309 3/20 0.35
CACNA2D1 P54289 1/20 0.34
OPRD1 P41143 1/20 0.34
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HIF1A Q16665 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654053 0.91 HRH3 (0.60) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7665094 0.88 HRH3 (0.60) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7664398 0.88 HRH3 (0.56) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7656338 0.84 HRH3 (0.66) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7657287 0.83 HRH3 (0.64) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7661605 0.83 HRH3 (0.64) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7656388 0.82 HRH3 (0.65) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7662209 0.81 HRH3 (0.59) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7654067 0.80 HRH3 (0.60) HRH3OPRM1NPFFR1NPFFR2OPRK1
SCHEMBL7655725 0.77 HRH3 (0.66) HRH3RAB9AOPRM1NPFFR1NPFFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085861-A1 IMIDAZOLIDINE COMPOUNDS AND THEIR USE AS CXCR3 ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-31 WO disclosed
US-6469002-B1 COMPOUNDS WHICH MODULATE CHEMOKINE RECEPTOR ACTIVITY AND ARE USEFUL IN TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. 2002-10-22 US disclosed